High dose daily amifostine and hypofractionated intensively accelerated radiotherapy for locally advanced breast cancer. A phase I/II study and report on early and late sequellae.

Koukourakis, M I

High dose daily amifostine and hypofractionated intensively accelerated radiotherapy for locally advanced breast cancer. A phase I/II study and report on early and late sequellae. [electronic resource] - Anticancer research - 2973-8 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article

0250-7005


Adult
Aged
Amifostine--administration & dosage
Arm--pathology
Brachial Plexus--radiation effects
Breast--pathology
Breast Neoplasms--mortality
Dose Fractionation, Radiation
Drug Administration Schedule
Edema--etiology
Feasibility Studies
Female
Fibrosis
Humans
Hypotension--chemically induced
Middle Aged
Peripheral Nervous System Diseases--etiology
Pulmonary Fibrosis--etiology
Radiation Injuries--epidemiology
Radiation Pneumonitis--etiology
Radiation-Protective Agents--administration & dosage
Radiodermatitis--etiology
Radiotherapy, High-Energy--adverse effects
Severity of Illness Index
Survival Analysis
Treatment Outcome
Vomiting--chemically induced